Veronica Tayson

Veronica Tayson, RPh, currently serves as the Director of Quality and Regulatory Affairs at Curium Pharma, focusing on radiopharmaceuticals and nuclear medicine since February 2024. Prior experience includes roles as Associate Director of Regulatory Affairs at KalVista Pharmaceuticals, Inc., where the emphasis was on rare diseases, and as a Regulatory Affairs Project Manager at Abbott, contributing to global regulatory affairs development and strategy. Veronica Tayson also held senior regulatory positions at Bristol Myers Squibb, overseeing immuno-oncology regulatory activities for the UK and Ireland, as well as global regulatory sciences in immunology and neuroscience. Earlier roles include Global Senior Regulatory Affairs Specialist at Worldwide Clinical Trials and Regulatory Affairs Pharmacist/Executive at APLC, along with work as a Medical Technical Officer at North Middlesex Hospital. Educational qualifications include a BSc in Pharmacy from MCU.